Activity of Cefiderocol and Comparators against Isolates from Cancer Patients

被引：49
|
作者：
Rolston, Kenneth V. I. [1 ]
Gerges, Baghat [1 ]
Shelburne, Samuel [1 ]
Aitken, Samuel L. [2 ]
Raad, Issam [1 ]
Prince, Randall A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Div Pharm, Houston, TX 77030 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2020年 / 64卷 / 05期
关键词：
Gram-negative isolates; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; cefiderocol; VITRO ANTIMICROBIAL ACTIVITY; SIDEROPHORE CEPHALOSPORIN; S-649266;
D O I：
10.1128/AAC.01955-19
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Cefiderocol inhibited 97.5% of 478 Gram-negative isolates from cancer patients at <= 4 mg/liter. It had potent activity against extended-spectrum beta-lactamase-positive Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae (CRE), and nonfermenting Gram-negative bacilli, including Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Acinetobacter species isolates. Amikacin, ceftazidime-avibactam, and meropenem had appreciable activity against non-CRE Enterobacteriaceae. No comparators were active against multidrug-resistant P. aeruginosa isolates. Only trimethoprim-sulfamethoxazole had appreciable activity against S. maltophilia isolates. Overall, cefiderocol was associated with the lowest level of resistance.
引用
收藏
页数：7
相关论文
共 50 条
  • [1] In vitro activity of cefiderocol and comparators against Gram-negative bacterial isolates from a series of surveillance studies in England: 2014-2018
    Gant, Vanya
    Hussain, Abid
    Bain, Malcolm
    Longshaw, Christopher
    Henriksen, Anne Santerre
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 27 : 1 - 11
  • [2] In vitro activity of ceftaroline and comparators against bacterial isolates collected globally from patients with skin infections
    Pierard, Denis
    Stone, Gregory G.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 26 : 4 - 10
  • [3] Activity of temocillin and comparators against clinical isolates of Vibrio cholerae from Iran
    Rahbar, Mohammad
    Saboorian, Rogieh
    Van de Velde, Sebastien
    Farzami, Marjan Rahnamaye
    Mardani, Masoud
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (03) : 615 - 616
  • [4] Activity of temocillin and comparators against clinical isolates of Vibrio cholerae from Iran
    Mohammad Rahbar
    Rogieh Saboorian
    Sebastien Van de Velde
    Marjan Rahnamaye Farzami
    Masoud Mardani
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 615 - 616
  • [5] In vitro activity of newer β-lactam/β-lactamase inhibitor combinations, cefiderocol, plazomicin and comparators against carbapenemase-producing Klebsiella pneumoniae isolates
    Maraki, Sofia
    Mavromanolaki, Viktoria Eirini
    Stafylaki, Dimitra
    Scoulica, Effie
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (07) : 596 - 600
  • [6] Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of Acinetobacter baumannii Clinical Isolates
    Balleste-Delpierre, Clara
    Ramirez, Angel
    Munoz, Laura
    Longshaw, Christopher
    Roca, Ignasi
    Vila, Jordi
    ANTIBIOTICS-BASEL, 2022, 11 (02):
  • [7] Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patients
    Sader, Helio S.
    Fritsche, Thomas R.
    Jones, Ronald N.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (02) : 291 - 295
  • [8] COMPARATIVE ACTIVITY OF CEFIDEROCOL ON BLOODSTREAM INFECTION ISOLATES FROM US ICU PATIENTS
    Nguyen, Sean
    DeJonge, Boudewijn
    Bryowsky, Jason
    Maher, Joshua
    Mendes, Rodrigo
    Miki, Takemura
    Yamano, Yoshinori
    CRITICAL CARE MEDICINE, 2024, 52
  • [9] Activity of tigecycline and comparators against recent clinical isolates of Finegoldia magna from Europe
    S. P. Hawser
    European Journal of Clinical Microbiology & Infectious Diseases, 2010, 29 : 1011 - 1013
  • [10] Activity of tigecycline and comparators against recent clinical isolates of Finegoldia magna from Europe
    Hawser, S. P.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2010, 29 (08) : 1011 - 1013
12345